You don’t know what you are talking about. There are retail names on the S-1, none that we’re invested through Noble. Only Noble investor that got an allocation was an Asian based pharma company for $4m. The other retail investors are affiliates of the company. Don’t speak of what you don’t know. You lose credibility.